Physician

Jonathan Lance Underwood, MD

According to 2025 Medicare claims, Jonathan Underwood, MD (NPI: 1265612972) practices internal medicine in the Valdosta, GA market, with the plurality of this provider's patient population coming from Lowndes, GA. This provider's primary affiliated billing organization is SGMC PHYSICIAN NETWORK INC (NPI: 1417597170; TIN: 84-3707279) and primary practice location at 31605-1029. Underwood is affiliated with the Privia Quality Network of Georgia (ACO ID: A3236) and PRIVIA QUALITY NETWORK - I LLC (ACO ID: A5533), participating under the MSSP model.

Underwood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 493 traditional Medicare patients, billed 11,991 HCPCS/CPT codes, and received $249,513 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 18,212 prescription claims across 732 beneficiaries totaling $1,614,868 in drug costs, led by Ozempic (Semaglutide). DME data shows 804 claims. Open Payments data shows 18 records totaling $364. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $483,837 to $249,513. In contrast, Part D prescription costs have risen steadily, from $1,148,573 to $1,614,868. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $70,465 and ending at $45,147.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	840	27,324	$483,837
2016	911	21,049	$485,194
2017	814	19,629	$489,222
2018	801	20,769	$404,748
2019	735	15,727	$352,677
2020	641	9,269	$257,755
2021	603	10,143	$332,654
2022	567	6,630	$285,198
2023	540	6,656	$269,400
2024	493	11,991	$249,513

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	771	18,052	$1,148,573
2016	743	16,292	$1,116,279
2017	693	14,201	$990,204
2018	741	14,229	$1,135,950
2019	702	14,783	$1,205,018
2020	709	14,993	$1,207,187
2021	722	15,934	$1,255,089
2022	719	16,407	$1,319,324
2023	728	16,446	$1,598,555
2024	732	18,212	$1,614,868

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	567	1,431	$74,450
2016	435	1,274	$44,517
2017	422	1,101	$36,026
2018	456	1,154	$35,018
2019	388	1,082	$37,288
2020	385	1,149	$57,701
2021	406	1,093	$59,752
2022	367	989	$53,519
2023	382	1,010	$52,583
2024	296	804	$39,300

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	320	320	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	475	1,230	$79
99497	Advance care planning, first 30 minutes	343	348	$75
96372	Injection of drug or substance under skin or into muscle	230	728	$9
36415	Insertion of needle into vein for collection of blood sample	437	943	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	202	7,762	$254,394
Januvia	Sitagliptin Phosphate	144	9,500	$169,507
Mounjaro	Tirzepatide	82	3,192	$117,397
Trulicity	Dulaglutide	78	3,136	$104,799
Eliquis	Apixaban	66	3,848	$74,878

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	31	$10,158
A7030	Full face mask used with positive airway pressure device, each	N	25	57	$4,662
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	29	72	$3,898
A7032	Cushion for use on nasal mask interface, replacement only, each	N	18	39	$3,643
E0601	Continuous positive airway pressure (cpap) device	Y	19	109	$3,607

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$364	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan Lance Underwood, MD?

Tedicare shows public-source Medicare data for Jonathan Lance Underwood, MD (NPI 1265612972), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Lance Underwood, MD have ACO affiliation data?

Jonathan Lance Underwood, MD is shown with ACO affiliation data for Privia Quality Network of Georgia (MSSP, ACO ID A3236) and PRIVIA QUALITY NETWORK - I LLC (MSSP, ACO ID A5533).

What billing organization is linked to Jonathan Lance Underwood, MD?

Jonathan Lance Underwood, MD is linked to SGMC PHYSICIAN NETWORK INC (billing NPI 1417597170) in the available physician profile data.

Does Jonathan Lance Underwood, MD have Open Payments data?

Jonathan Lance Underwood, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.